Sutro Biopharma Ownership | Who Owns Sutro Biopharma?
Sutro Biopharma Ownership Summary
Sutro Biopharma is owned by 77.77% institutional investors, 0.96% insiders, and 21.27% retail investors. Blackrock is the largest institutional shareholder, holding 11.24% of STRO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.93% of its assets in Sutro Biopharma shares.
STRO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Sutro Biopharma | 77.77% | 0.96% | 21.27% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 6.91M | 11.24% | $20.25M |
| Suvretta capital management | 7.71M | 9.49% | $22.59M |
| Millennium management | 4.36M | 7.10% | $12.78M |
| Vanguard group | 3.56M | 5.79% | $10.42M |
| Point72 asset management | 4.45M | 5.48% | $13.03M |
| Bioimpact capital | 3.04M | 3.75% | $8.92M |
| Geode capital management | 1.72M | 2.81% | $5.05M |
| Samsara biocapital | 2.20M | 2.70% | $6.44M |
| State street | 1.57M | 2.55% | $4.59M |
| Kynam capital management, lp | 2.02M | 2.49% | $5.93M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Aquilo capital management | 762.50K | 2.15% | $2.23M |
| Bioimpact capital | 3.04M | 1.39% | $8.92M |
| Samsara biocapital | 2.20M | 1.35% | $6.44M |
| Suvretta capital management | 7.71M | 0.83% | $22.59M |
| Parkman healthcare partners | 1.79M | 0.70% | $5.25M |
| Kynam capital management, lp | 2.02M | 0.46% | $5.93M |
| Eversept partners, lp | 1.74M | 0.35% | $5.10M |
| Dafna capital management | 329.58K | 0.23% | $965.67K |
| Ubs oconnor | 275.06K | 0.05% | $805.92K |
| Point72 asset management | 4.45M | 0.03% | $13.03M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 4.45M | 0.03% | 4.19M |
| Suvretta capital management | 7.71M | 0.83% | 1.93M |
| Blackrock | 6.91M | 0.00% | 1.21M |
| Eversept partners, lp | 1.74M | 0.35% | 647.71K |
| Nuveen asset management | 905.44K | 0.00% | 567.82K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bioimpact capital | 3.04M | 1.39% | -1.05M |
| Schonfeld strategic advisors | 634.20K | 0.01% | -488.90K |
| Candriam s.c.a. | - | - | -440.42K |
| Aquilo capital management | 762.50K | 2.15% | -402.97K |
| Millennium management | 4.36M | 0.01% | -374.07K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Lpl financial | 230.15K | 0.00% | 230.15K | $674.34K |
| Qube research | 70.61K | 0.00% | 70.61K | $206.90K |
| Alps advisors | 63.78K | 0.00% | 63.78K | $186.89K |
| Corebridge financial | 44.04K | 0.00% | 44.04K | $129.04K |
| Nomura | 43.43K | 0.00% | 43.43K | $127.24K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -13.00 |
| Zurcher kantonalbank (zurich cantonalbank) | -285.00 |
| Metropolitan life insurance co/ny | -1.63K |
| Quantbot technologies lp | -2.10K |
| Principal financial group | -10.85K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 122 | 3.39% | 63,167,394 | 18.26% | 77 | 1.03% | 79 | 16.18% | 28 | -12.50% |
| Mar 31, 2024 | 118 | 3.51% | 53,412,278 | -3.97% | 86 | 1.05% | 68 | 11.48% | 32 | 10.34% |
| Dec 31, 2023 | 114 | 3.64% | 55,621,581 | -0.54% | 91 | 1.07% | 61 | 22.00% | 29 | -12.12% |
| Sep 30, 2023 | 110 | -9.09% | 55,925,507 | 3.50% | 92 | 1.15% | 50 | -21.88% | 33 | -8.33% |
| Jun 30, 2023 | 121 | 4.31% | 54,032,251 | 0.72% | 89 | 1.07% | 64 | -5.88% | 36 | 28.57% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.42M | 2.93% | - |
| iShares Russell 2000 ETF | 2.09M | 2.56% | -4.70K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.19M | 1.45% | -2.21K |
| CREF Stock R1 | 961.49K | 1.17% | - |
| Baillie Gifford Global Discovery A Acc | 910.44K | 1.11% | -135.97K |
| Fidelity Small Cap Index | 839.42K | 1.02% | -20.06K |
| iShares Russell 2000 Value ETF | 771.08K | 0.94% | - |
| Edinburgh Worldwide Ord | 750.73K | 0.92% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 510.25K | 0.62% | -16.80K |
| Goldman Sachs Small Cp Val Insghts Instl | 467.61K | 0.57% | 110.43K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 29, 2024 | Vasquez Nicki | CHIEF PORT. STRAT & ALNCE OFCR | Sell | $60.92K |
| Aug 28, 2023 | Shtylla Brunilda | Chief Business Officer | Sell | $72.59K |
| Aug 25, 2023 | Shtylla Brunilda | Chief Business Officer | Sell | $53.28K |
| Mar 14, 2022 | NEWELL WILLIAM J | CEO | Buy | $77.51K |
| Sep 28, 2021 | Vasquez Nicki | Chief Port. Strat & Alnce Ofcr | Sell | $72.72K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 1 |
| 2023 Q4 | - | - |
| 2023 Q3 | - | 2 |
STRO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools